Keiko Ohgino

Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC

Hideki Terai, Kenzo Soejima, Hiroyuki Yasuda et al. · Molecular Cancer Research · 2013 · 205 citations

Pathology, Tumor Biology, Oncology +19

Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer

Masayoshi Miyawaki, Hiroyuki Yasuda, Tetsuo Tani et al. · Molecular Cancer Research · 2016 · 71 citations · Full text

Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in <i>ALK</i> -Translocated Lung Cancer Cells

Tetsuo Tani, Hiroyuki Yasuda, Junko Hamamoto et al. · Molecular Cancer Therapeutics · 2015 · 61 citations · Full text

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer

Keiko Ohgino, Kenzo Soejima, Hiroyuki Yasuda et al. · Lung Cancer · 2013 · 49 citations · Full text

Oncology, Medicine, Pathology +9

Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers

Takashi Sato, Kenzo Soejima, Daisuke Fujisawa et al. · The Oncologist · 2018 · 44 citations · Full text